glp 1 receptor agonists are contraindicated in contraindications to π°οΈ60-second review: Mnemonics and Updates GLP -1 in A Closer Look at the
Description
Click on the Pharmacy tab

The observed clinical benefits appear to stem primarily from weight loss rather than direct analgesic mechanisms

However, based on six exenatide and five liraglutide placebo-controlled studies ( P =0.055 and P =0.31, respectively), significance was not reached for individual GLP-1RA with an OR of 0.45 (95% CI 0.20, 1.02) for exenatide and 0.60 (95% CI 0.22, 1.62) for liraglutide

References Burke, O., Sa, B., Cespedes, D
